1 completed, 1 enrolling by invitation, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Enrolling by invitation 1, Not yet recruiting 1 |
Follow Drug Resistance: new trials by email Literature Review of Drug Resistance trials Research Report on Drug Resistance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor Rifaximin - ACS - Acute Coronary Syndrome, Ticagrelor | Phase 4 | Not yet recruiting | Collegium Medicum w Bydgoszczy | 50 | 2026-01-01 | 2025-10-02 |
| B-free Multistage Trial DOR/DTG/3TC - HIV, Drug Resistance | Phase 4 | Enrolling by invitation | Insel Gruppe AG, University Hospital Bern | 210 | 2023-11-13 | 2024-12-04 |
| Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in Gabon Benzimidazole Anthelmintic - Helminths Infection, Drug Resistance | Phase 4 | Completed | Centre de Recherche Médicale de Lambaréné | 255 | 2019-11-11 | 2021-08-02 |
Acute Coronary Syndrome (1) · Dysbiosis (1) · Infections (1) · Myocardial Infarction (1)
Cardiovascular Diseases (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1) · Myocardial Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
Albendazole (1) · Lamivudine (1) · Mebendazole (1) · Pyrantel (1) · Rifaximin (1) · dolutegravir (1) · doravirine (1)
Centre de Recherche Médicale de Lambaréné (1) · Collegium Medicum w Bydgoszczy (1) · Insel Gruppe AG, University Hospital Bern (1)
Gabon (1) · Poland (1) · Switzerland (1)
Gilles Wandeler, Prof (1) · Jacek Kubica, Prof. (1)